Bluemist® Medical Sanitation
A Global Health Problem
Each year in the U.S. more than 2 million people are infected with drug-resistant bacteria, which cause the deaths of more than 23,000 people, according to the U. S. Centers for Disease Control and Prevention. Antibiotic-resistant "superbugs” are a global public health concern and some of the most dangerous superbugs, such as MRSA and Clostridium Difficile, infect patients within the health care environment. Therefore, improving the disinfection of hospital rooms and health care facilities is a critical global challenge with no apparent comprehensive solution.
The Bluemist® Solution
Bluemist®, developed by Somnio Global, is a highly effective, water based device that is able to rapidly and effectively sanitize medical rooms and facilities. Using Somnio Global’s patented Free Radical Generation Technology, a penetrating fog is produced to kill any bacteria/spores present within the treatment environment. Water is converted into a fine mist which is then run through a reactor that converts the mist into powerful and unstable radicals (ionized species). These compounds have a short shelf life, but attack anything living, such as superbugs. They then revert to a benign substance. The system requires no chemicals to operate, deposits no residue, and is fully automatic and safe.
Market Potential
Infection rates associated with health care are increasingly driving costs in the industry, providing a global opportunity for a new technology to establish market leadership. The total cost to the global economy could reach U.S. $100 trillion by 2050 and kill more than 10 million people each year, a threat that warrants as much attention as climate change, according to a review led by economist Jim O’Neill. According to the CDC, in the U.S. alone, antibiotic-resistant infections are annually responsible for over U.S. $20 billion in excess healthcare costs and more than 8 million additional hospital days.
Value Proposition
The Bluemist® system is aiming to provide the following competitive advantages:
- More effective and lower-cost than competing technologies.
- 10-log destruction of superbugs and C. Difficile.
- Hospital room (Standard Size) treatment time of less than one hour.
- Immediate drying of the vapor with no residue.
- Only consumables required are water and electricity.
- Non-destructive to the infrastructure.
- High penetration to gaps, cracks and porous materials.
